These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 27264314)
1. A high-throughput-compatible assay to measure the degradation of endogenous Huntingtin proteins. Wu P; Lu MX; Cui XT; Yang HQ; Yu SL; Zhu JB; Sun XL; Lu B Acta Pharmacol Sin; 2016 Sep; 37(10):1307-1314. PubMed ID: 27264314 [TBL] [Abstract][Full Text] [Related]
2. TR-FRET Assays for Endogenous Huntingtin Protein Level in Mouse Cells. Liang Y; Yao Y; Lu M; Hou J; Yu S; Lu B J Huntingtons Dis; 2014; 3(3):253-9. PubMed ID: 25300329 [TBL] [Abstract][Full Text] [Related]
4. Drugging unconventional targets: insights from Huntington's disease. Yu S; Liang Y; Palacino J; Difiglia M; Lu B Trends Pharmacol Sci; 2014 Feb; 35(2):53-62. PubMed ID: 24388390 [TBL] [Abstract][Full Text] [Related]
5. Huntington's Disease Protein Huntingtin Associates with its own mRNA. Culver BP; DeClercq J; Dolgalev I; Yu MS; Ma B; Heguy A; Tanese N J Huntingtons Dis; 2016; 5(1):39-51. PubMed ID: 26891106 [TBL] [Abstract][Full Text] [Related]
6. Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative. Tomoshige S; Nomura S; Ohgane K; Hashimoto Y; Ishikawa M Bioorg Med Chem Lett; 2018 Feb; 28(4):707-710. PubMed ID: 29366651 [TBL] [Abstract][Full Text] [Related]
7. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. Lu B; Palacino J FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320 [TBL] [Abstract][Full Text] [Related]
8. Development of a method for the high-throughput quantification of cellular proteins. Paganetti P; Weiss A; Trapp M; Hammerl I; Bleckmann D; Bodner RA; Coven-Easter S; Housman DE; Parker CN Chembiochem; 2009 Jul; 10(10):1678-88. PubMed ID: 19492395 [TBL] [Abstract][Full Text] [Related]
9. Degradation of mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65. Chow WN; Luk HW; Chan HY; Lau KF Biochem J; 2012 May; 443(3):681-9. PubMed ID: 22352297 [TBL] [Abstract][Full Text] [Related]
11. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions. Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730 [TBL] [Abstract][Full Text] [Related]
12. Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight. Gopalakrishnan C; Jethi S; Kalsi N; Purohit R Cell Biochem Biophys; 2016 Jun; 74(2):129-39. PubMed ID: 27094178 [TBL] [Abstract][Full Text] [Related]
13. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo. Huang B; Schiefer J; Sass C; Landwehrmeyer GB; Kosinski CM; Kochanek S Hum Gene Ther; 2007 Apr; 18(4):303-11. PubMed ID: 17472569 [TBL] [Abstract][Full Text] [Related]
14. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion. Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195 [TBL] [Abstract][Full Text] [Related]
15. Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity. Dong G; Gross K; Qiao F; Ferguson J; Callegari EA; Rezvani K; Zhang D; Gloeckner CJ; Ueffing M; Wang H J Neurochem; 2012 Nov; 123(3):437-46. PubMed ID: 22891683 [TBL] [Abstract][Full Text] [Related]
16. A novel function of Huntingtin in the cilium and retinal ciliopathy in Huntington's disease mice. Karam A; Tebbe L; Weber C; Messaddeq N; Morlé L; Kessler P; Wolfrum U; Trottier Y Neurobiol Dis; 2015 Aug; 80():15-28. PubMed ID: 25989602 [TBL] [Abstract][Full Text] [Related]
17. Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease. Skogen M; Roth J; Yerkes S; Parekh-Olmedo H; Kmiec E BMC Neurosci; 2006 Oct; 7():65. PubMed ID: 17014717 [TBL] [Abstract][Full Text] [Related]
20. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease. Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]